En español
NIDA

Menu

Blending Addiction Science & Practice: Bridges to the Future

Revised June 2012

2006 Meeting Overview:

This two-day conference held October 16-17, 2006 in Seattle, Washington provided an important opportunity for clinicians and providers to interact with the developers of empirically supported treatments in awareness-raising workshops focused on treatment implementation.

The meeting included a plenary presentation each morning (delivered by Drs. Nora Volkow and A. Thomas McLellan, respectively). The event also incorporated an afternoon presentation by Dr. Mary Jeanne Kreek regarding the genetics of addiction, and the Eileen Pencer Memorial Lecture, delivered by Ms. Jeanne Obert of the Matrix Institute. A total of 24 breakout sessions were conducted as well.

This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the National Institute on Drug Abuse, National Institutes of Health/Foundation for Advanced Education in the Sciences (NIH/FAES), The University of Washington, and Oregon Health & Science University.

Goals and Objectives

The goal of this year’s Blending Addiction Science & Practice Conference was to improve addiction treatment practices to enable more individuals to recover from addiction disorders.

The objectives were:

  • To enhance bi-directional communication between drug abuse and addiction researchers and community treatment providers.
  • To increase drug abuse and addiction practitioner’s level of knowledge regarding NIDA’s research.
  • To increase awareness, knowledge and use of the Blending Team Products.
  • To advance the exchange of ideas among drug abuse and addiction professionals.
  • To guide drug abuse and addiction practitioners to additional resources for knowledge and skill development of science-based practices.
  • To increase the dissemination of science-based practices for the treatment of drug abuse and addictive disorders.

Agendas:

Meeting Day 1

Begin End Session Faculty
7:00 a.m. 9:00 a.m Registration
9:00 a.m. 9:30 a.m Opening Remarks Timothy P. Condon, Ph.D.
Introductions Dennis M. Donovan, Ph.D.
Welcoming Speaker Robin Arnold-Williams, D.S.W.
9:30 a.m. 11:00 a.m Plenary Presentation - Moving From Bench to Bedside to Community: Research-Practice Partnerships Are Making It Possible Nora D. Volkow, M.D.
11:00 a.m. 11:15 a.m. Break
11:15 a.m. 12:45 p.m. Morning Breakout Sessions
S.M.A.R.T. Treatment Planning Using the ASI: Perspectives on Research, Dissemination, and Provider Application Deni Carise, Ph.D.
Pat Stilen, LCSW, CADAC
Ron Jackson, M.S.W.
Healing Co-Occurring Trauma and Substance Use in Adolescents Cynthia L. Rowe, Ph.D.
Lucy Zammarelli, M.A.
Challenges in Determining Best Practices in Criminal Justice Michele Staton-Tindall, Ph.D., M.S.W.
Patricia Noble-Desy, M.A.
Felisia Otis
Neurocognition and Methamphetamine Dependence Sara L. Simon, Ph.D.
Andrew J. Saxon, M.D.
Lisa C. Romwall, M.A., CDP
Integrated Treatment for Trauma and Addiction: Seeking Safety Denise Hien, Ph.D.
Tracy L. Simpson, Ph.D.
The Role of Clinical Supervision in Learning, Adopting, and Maintaining Evidence-Based Practice Kathleen M. Carroll, Ph.D.
Kathyleen Tomlin, L.P.C., CADC III
12:45 p.m. 2:30 p.m. Afternoon Presentation - Research on Genetics of Addiction: Critical Role of and Rewards for Clinicians Mary Jeanne Kreek, M.D.
2:30 p.m. 2:45 p.m Break
2:45 p.m. 4:00 p.m. Afternoon Breakout Sessions
Understanding and Utilizing Buprenorphine in the Treatment of Opioid Addiction Susan A. Storti, Ph.D., R.N.
Joshua Boverman, M.D.
Andrew J. Saxon, M.D.
Bill Dickinson, D.O., FASAM, FAAFP
Sexual Risk-Reduction Interventions for Substance Abuse Treatment Programs Donald A. Calsyn, Ph.D.
Susan Tross, Ph.D.
Carol Davidson, M.S.W., CPD
Drug Courts: What is the Evidence? Douglas B. Marlowe, J.D., Ph.D.
Norma D. Jaeger, M.S.
What can Neuroscience Offer Addiction Treatment? William F. Hoffman, M.D., Ph.D.
Glen R. Hanson, Ph.D., D.D.S.
Jeanne Obert, M.F.T., MSM
What is Gender-Specific Treatment for Women? Shelly Greenfield, M.D., M.P.H.
Sharon A. Chambers, M.S.W., LICSW, CDP
How is Evidence-Based Practice Defined and What Does it Mean to Implement Evidence-Based Practices Dean Fixsen, Ph.D.
William R. Miller,Ph.D.
Joan E. Zweben, Ph.D.
4:00 p.m. 4:15 p.m. Break
4:15 p.m. 5:30 p.m. Afternoon Breakout Sessions Continued

Meeting Day 2

Begin End Session Faculty
7:00 a.m. 9:00 a.m. Registration & Poster Session
9:00 a.m. 10:00 a.m. Introductions Dennis M. Donovan, Ph.D.
Dennis McCarty, Ph.D.
10:00 a.m. 11:00 a.m. Plenary Presentation - Reconsidering Addiction Treatment: Implications from a Business Perspective A. Thomas McLellan, Ph.D.
11:00 a.m. 11:15 a.m. Break
11:15 a.m. 12:45 p.m. Morning Breakout Sessions
Promoting Awareness of Motivational Incentives Lonnetta Albright
Maxine Stitzer, Ph.D.
John Hamilton, LMFT, LADC
Treating Adolescent Marijuana Use Roger A. Roffman, D.S.W.
Douglas K. O’Dell, M.S.
Juvenile Justice: The Reclaiming Futures Project Laura Burney Nissen, Ph.D.
Addiction Treatments of the Future: The Role of Genetics Laura J. Bierut, M.D.
Louise Haynes, M.S.W.
Allan J. Cohen, M.A., MFT
Evidence-Based Treatment and Services Research for Latino/a Patients Margarita Alegría, Ph.D.
Christiane Farentinos, M.D., M.P.H., CADC II
What is the Evidence for 12-Step Support and Facilitation Therapy? Dennis M. Donovan, Ph.D.
Patricia C. Knox, Ph.D.
Brenda Middleton, CDP
12:45 p.m. 2:30 p.m. Eileen Pencer Memorial Lecture Jeanne L. Obert, MFT, MSM
2:30 p.m. 2:45 p.m. Break
2:45 p.m. 4:00 p.m. Afternoon Breakout Sessions
MIA: STEP - Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency Steven L. Gallon, Ph.D.
Steve Martino, Ph.D.
Christiane Farentinos, M.D., M.P.H., CADC II
Evidence-Based Assessment with Adolescents Ken C. Winters, Ph.D.
Michael Dennis, Ph.D.
Ramona Graham, ICADC, CDP
Evidence-Based Treatment in Correctional Settings Michael L. Prendergast, Ph.D.
Bart Murray, M.A.
Pain Management in Addiction Treatment Settings Deborah L. Haller, Ph.D., ABPP
Joseph O. Merrill, M.D., M.P.H.
Bradley M. Anderson, M.D.
Needs of American Indian/Alaskan Native Treatment Programs:  How Evidence-Based Practices and Research Fit into the Community R. Dale Walker, M.D.
Lisa Rey Thomas, Ph.D.
C. Truth Griffeth, M.S.W., NCAC I, CDP
Why and How To Treat Tobacco Dependence in Addictions Settings Kimber Paschall Richter, Ph.D., M.P.H.
Eric E. Schindler, Ph.D.
4:00 p.m. 4:15 p.m. Break
4:15 p.m. 5:30 p.m. Afternoon Breakout Sessions Continued

 

This page was last updated June 2012

    National Drug Abuse Treatment Clinical Trials Network: Search listings of drug abuse clinical trials, click here

    Looking for Treatment?

    Use the SAMHSA Treatment Locator or 1-800-662-HELP.